Updates
Sub: Resignation of Company Secretary cum Compliance officer with effect from16.11.2017 With reference to the subject cited, this is to inform the Exchange that Ms.AakankshaShukla, Company Secretary cum Compliance officer of M/s. Concord Drugs Limitedhas resigned from the said post with effect from 16.11.2017 due to her pre-occupations. This is for the information and records of the Exchange, please. Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for S Nagi Reddy Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for S Manoj Kumar Reddy Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for S Koni Reddy Outcome of Board Meeting
Allotment of shares/warrants to the promoters and others on preferential basis at an issue price of Rs.48 per share/warrant. Intimation Of Board Meeting To Be Held On 15.11.2017
Sub: Intimation of Board meeting to be held on 15.11.2017 Ref: Scrip Code 538965 With reference to the subject cited, this is to inform the Exchange that the meeting of the Board of Directors of M/s. Concord Drugs Limited will be held on Wednesday, 15.11.2017 at 04:30 p.m. at the registered office of the company at Survey No.249, Brahmanapally Village,Hayatnagar,Mandal-501511,Telangana to consider the following:... Compliance Certificate For The Period Ended 30.09.2017
Compliance Certificate for the period ended 30.09.2017 PCS Certificate For The Half Year Ended 30.09.2017
PCS Certificate for the half year ended 30.09.2017 Shareholding for the Period Ended September 30, 2017
Concord Drugs Ltd has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2017. For more details, kindly Click here Statement Of Investor Complaints For The Quarter 30.09.2017
statement of Investor COMplaints for the quarter 30.09.2017